先看重點
在24項隨機試驗、共8933名參與者中,移動健康(mHealth)自我管理使收縮壓比對照組多降低3.78 mm Hg,舒張壓多降低1.57 mm Hg。所有研究均被評為高偏倚風險,效應可能被高估。
證據類型
證據回顧
解讀依據
公開摘要
閱讀重點
方法與適用範圍
研究在問什麼
高血壓需要認真的自我管理,移動技術也越來越多地用於支援這一點。研究者彙總了面向成人高血壓患者的mHealth試驗,考察血壓、血壓控制、服藥依從性、自我管理行為和費用。
研究對象與方法
系統評價和統合分析,並輔以敘述性綜合。檢索5個電子資料庫及參考文獻列表,納入2010年1月至2019年9月間發表的同行評議隨機對照試驗。3名研究者獨立提取資料並評估質量。共納入24項研究、8933名參與者:23項報告了血壓,12項提供了收縮壓(SBP)和舒張壓(DBP)資料用於統合分析,16項報告了行為改變和依從性。已在PROSPERO註冊(CRD42019152062)。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1mHealth組的SBP下降幅度大於對照組,為-3.78 mm Hg(P<.001;95%置信區間-4.67至-2.89),DBP為-1.57 mm Hg(P<.001;95%置信區間-2.28至-0.86)。
- 2按提醒頻率、互動方式、介入功能和研究持續時間分層的亞組中,血壓降低的結果一致。
- 316項研究報告介入組服藥依從性和行為改善更好,8項顯示無顯著變化。
- 46項研究包含經濟學評價,結論不一致,但都提到了潛在的長期經濟收益。最成功的mHealth介入結合了個性化資訊、互動溝通和多種功能。
限制與不確定性
- 1所有研究均被評估為高偏倚風險,這會誇大表觀獲益。
- 224項研究中只有12項納入血壓統合分析,摘要也未報告異質性。
- 3摘要未說明使用了哪些應用或裝置,作者也呼籲開展更長時間的試驗並進行文化適應。本文解讀僅基於摘要。
日常健康啟示
帶有個性化、互動資訊和多種功能的手機專案,與血壓小幅下降相關,幅度類似某些小的生活方式改變。由於這些試驗全部為高偏倚風險,應把結果看作有希望而非定論。降壓藥物和血壓目標應由臨床醫師與你共同確定。
如何連結自己的資料
這與家庭血壓監測直接相關:使用經驗證的血壓計,每天在相同時間、坐位休息後測量,並在應用中記錄。比較每週平均值,把記錄交給臨床醫師,而不是對單次讀數作出反應。
如何理解這類證據
先看納入了哪些設計、文獻搜尋與偏誤評估如何完成,以及搜尋截止日期;發表新不代表底層證據都是最新的。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Effective treatment of hypertension requires careful self-management. With the ongoing development of mobile technologies and the scarcity of health care resources, mobile health (mHealth)-based self-management has become a useful treatment for hypertension, and its effectiveness has been assessed in many trials. However, there is a paucity of comprehensive summaries of the studies using both qualitative and quantitative methods.
Objective
This systematic review aimed to measure the effectiveness of mHealth in improving the self-management of hypertension for adults. The outcome measures were blood pressure (BP), BP control, medication adherence, self-management behavior, and costs.
Methods
A systematic search was conducted using 5 electronic databases. The snowballing method was used to scan the reference lists of relevant studies. Only peer-reviewed randomized controlled trials (RCTs) published between January 2010 and September 2019 were included. Data extraction and quality assessment were performed by 3 researchers independently, adhering to the validation guideline and checklist. Both a meta-analysis and a narrative synthesis were carried out.
Results
A total of 24 studies with 8933 participants were included. Of these, 23 studies reported the clinical outcome of BP, 12 of these provided systolic blood pressure (SBP) and diastolic blood pressure (DBP) data, and 16 articles focused on change in self-management behavior and medication adherence. All 24 studies were included in the narrative synthesis. According to the meta-analysis, a greater reduction in both SBP and DBP was observed in the mHealth intervention groups compared with control groups, -3.78 mm Hg (P<.001; 95% CI -4.67 to -2.89) and -1.57 mm Hg (P<.001; 95% CI -2.28 to -0.86), respectively. Subgroup analyses showed consistent reductions in SBP and DBP across different frequencies of reminders, interactive patterns, intervention functions, and study duration subgroups. A total of 16 studies reported better medication adherence and behavioral change in the intervention groups, while 8 showed no significant change. Six studies included an economic evaluation, which drew inconsistent conclusions. However, potentially long-term financial benefits were mentioned in all economic evaluations. All studies were assessed to be at high risk of bias.
Conclusions
This review found that mHealth self-management interventions were effective in BP control. The outcomes of this review showed improvements in self-management behavior and medication adherence. The most successful mHealth intervention combined the feature of tailored messages, interactive communication, and multifaceted functions. Further research with longer duration and cultural adaptation is necessary. With increasing disease burden from hypertension globally, mHealth offers a potentially effective method for self-management and control of BP. mHealth can be easily integrated into existing health care systems.
Trial registration
PROSPERO CRD42019152062; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=152062.
來源與署名
The Effectiveness of Self-Management of Hypertension in Adults Using Mobile Health: Systematic Review and Meta-Analysis.
Li R, Liang N, Bu F, Hesketh T.
JMIR mHealth and uHealth · 2020-03-27
DOI: 10.2196/17776 ↗PubMed · 32217503 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
晝夜活動節律紊亂與更高的死亡風險相關(109,365人)
在7項觀察性研究、共109,365名參與者中,晝夜活動對比較弱(相對振幅較低)與更高的心血管死亡風險(風險比[HR]1.50,95%置信區間1.13至1.98)和全因死亡風險(HR 1.46,95%置信區間1.27至1.68)相關。證據基礎小,又是觀察性的,不能說明改善節律就能降低風險,疾病本身也可能擾亂節律。
Journal of the American Heart Association
五類運動都降低了靜息血壓,等長訓練降幅最大
彙總270項隨機試驗、共15,827名參與者的結果,有氧、抗阻、聯合、間歇和等長訓練與無介入對照組相比都降低了靜息血壓(各P<0.001),其中等長訓練降幅最大:收縮壓下降8.24 mm Hg,舒張壓下降4.00 mm Hg。各方式之間的排序部分來自間接比較,各試驗也不盡相同,所以排序不是個人的運動處方。
British Journal of Sports Medicine
鹽替代品使中國農村高危族群的中風、主要心血管事件和死亡率下降
在中國農村600個村莊、20,995名有中風史或年齡在60歲及以上且有高血壓的人中,使用鹽替代品(氯化鈉75%、氯化鉀25%)的中風發生率低於普通鹽:平均追蹤4.74年,每1000人年29.14次對33.65次(率比0.86,95%置信區間0.77至0.96;P=0.006)。死亡也更低(率比0.88),嚴重高鉀血癥事件沒有顯著增多,但試驗為開放標籤設計,且在中國農村開展。
The New England Journal of Medicine
智慧手錶脈搏不規則提醒較少見,做貼片檢查者34%確有房顫
在419,297名沒有已知心房顫動(房顫)的蘋果手錶使用者中,0.52%收到脈搏不規則提醒;返還可用心電貼片的450人中,34%確認有房顫(97.5%置信區間29至39)。提醒發出時恰有貼片記錄的,通知的陽性預測值為0.84(95%置信區間0.76至0.92),但收到提醒者中僅20.8%返還了貼片,沒有收到提醒的人未被監測,所以手錶沒有提醒並不能排除房顫。
The New England Journal of Medicine

